The exerkine apelin reverses age-associated sarcopenia
Claire Vinel, Laura Lukjanenko, Aurélie Batut et al. · Nature Medicine · 2018
Cited by 397 works. doi:10.1038/s41591-018-0131-6
Authors
- Claire Vinel
- Laura Lukjanenko
- Aurélie Batut
- Simon Deleruyelle
- Jean‐Philippe Pradère
- Sophie Le Gonidec
- Alizée Dortignac
- Nancy Geoffre
- Ophélie Péreira
- Sonia Karaz
- Umji Lee
- Mylène Camus
- Karima Chaoui
- Étienne Mouisel
- Anne Bigot
- Vincent Mouly
- Allan F. Pagano
- Angèle Chopard
- Fabien Pillard
References
- Frailty in Relation to the Accumulation of Deficits
- The Healthcare Costs of Sarcopenia in the United States
- Sarcopenia: Alternative Definitions and Associations with Lower Extremity Function
- Effect of Structured Physical Activity on Prevention of Major Mobility Disability in Older Adults
- Skeletal Muscle Fatigue: Cellular Mechanisms
- Effects of a Physical Activity Intervention on Measures of Physical Performance: Results of the Lifestyle Interventions and Independence for Elders Pilot (LIFE-P) Study
- Welcome to the ICD‐10 code for sarcopenia
- Frailty and cognitive impairment—A review of the evidence and causal mechanisms
- Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents
- [125I]‐(Pyr1)Apelin‐13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man